Inpatient Resource Use and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States

LaMori, Joyce; Shoheiber, Omar; Mody, Samir H.; Bookhart, Brahim

doi:10.1016/j.clinthera.2014.10.024

Cited by 65 publications

(52 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 The mean total hospitalization costs for treating a patient with PE ranges widely from $8,764 to $37,006, with an average reported length of stay between four and five days. 2,3 This cost range is attributed to many factors, including type of PE, therapy-induced bleeding risk requiring close monitoring, comorbidities, and social determinants of health. Given that patients with low-risk PE represent the majority of the cases, changes in approaches to care for this population can significantly impact the overall healthcare costs for PE.…”

mentioning

confidence: 99%

Cardiac Troponins in Low‐Risk Pulmonary Embolism Patients: A Systematic Review and Meta‐Analysis

Darwish

Mahayni

Patel

et al. 2018

Journal of Hospital Medicine

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Cardiac Troponins in Low‐Risk Pulmonary Embolism Patients: A Systematic Review and Meta‐Analysis

Darwish

Mahayni

Patel

et al. 2018

Journal of Hospital Medicine

View full text Add to dashboard Cite

show abstract

“…Using this method could underrepresent the number of those effected by PTS. 9 In a retrospective study by LaMori, Shoheiber, Mody, and Bookhart (2015), the economic burden of inpatient treatment of VTE was determined by analyzing the national database Nationwide Inpatient Sample (NIS). The Nationwide Inpatient Sample represents the largest database of hospital care data and collects information on over 1,000 hospitals within the United States.…”

Section: Economic Burden Of Vtementioning

confidence: 99%

Development of an Education Program for Registered Nurses Related to the Use and Function of Mechanical Prophylaxis

Garrison¹

2018

Preprint

View full text Add to dashboard Cite

Venous thromboembolism events (VTE) are one of nine hospital-acquired events monitored by organizations, such as The Joint Commission, that are considered preventable when the proper safeguards are in place. Practice recommendations by the National Institute for Health and Care Excellence and The American College of Chest Physicians include adhering to pharmacological and nonpharmacological therapy for at risk patients. In patients with contraindications to pharmacological prophylaxis, mechanical therapy provides adequate protection against VTE when used correctly. Registered nurses within the acute care setting are key players in ensuring that mechanical therapy is implemented and maintained at the bedside. The purpose of this quality improvement project was to assess nurse understanding on the use and function of mechanical prophylaxis. The project included a pretest, educational program, and posttest design on a surgical unit at Rhode Island Hospital. The Logic Model Framework guided the quality improvement project. Twenty-one nurses completed the pretest (66%) and 21 attended the educational sessions and completed the posttest (66%). Pretest scores ranged from 2.4 to 4.2 out of a possible 5 points for each question, with a mean response rate of 3.6. In comparison, posttest scores ranged from 3.5 to 4.6, with a mean response rate of 4.3. The average posttest response rate increased by 0.7 points. Seventeen nurses completed a program evaluation (n=17; 60%). Three themes were derived after analysis of open ended responses by nurses from the program evaluation. Overall, the findings supported increased understanding on the use and function of mechanical prophylaxis by nurses after attending the educational program. Further research is needed to determine if incorporating this educational program in new hire orientation or developing a formal nursing policy on mechanical prophylaxis would increase nurse and patient compliance.

show abstract

“…The annual cost per patient for an initial episode of PE in 2011 was estimated to be $13,000 to $31,300, and for a recurrent PE, $11,014 to $14,722 [8]. In a retrospective study by LaMori et al which examined hospital lengths of stay and associated charges among hospitalized patients with a primary diagnosis of deep venous thrombosis (DVT) or PE in ten states, hospital readmission for a recurrent DVT or PE occurred largely in the first 60 days after the index event.…”

Section: Introductionmentioning

confidence: 99%

“…As health care reforms increasingly subject hospital systems to 30-day readmission penalties, cost-containment strategies are being aggressively pursued. General proposals include the implementation of evidence-based therapies at the time of PE diagnosis, mechanisms to ensure post-discharge adherence to therapy, and appropriate continuity of care to reduce the incidence and frequency of hospital readmissions [8].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pulmonary Embolism Response Teams

Reza

Dudzinski

2015

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

Pulmonary embolism (PE) is a complex and multidimensional pathophysiology, the diagnosis and management of which spans multiple disciplines. The high morbidity and associated mortality of "massive" and "submassive" acute PE may require prompt, definitive management; however, current consensus guidelines in this domain are not supported by high-level evidence. Randomized clinical trials comparing available pharmacologic and invasive treatment modalities-including anticoagulation, thrombolysis, and embolectomy-have not been conducted and continue to be challenging to conceptualize, design, and execute. Consequently, time-sensitive therapeutic determinations are largely not standardized, and rendered on a case-by-case basis in part depending on institutional practices and expertises. Chronic sequelae of PE, such as chronic thromboembolic pulmonary hypertension and right heart failure, are increasingly identified as conditions necessitating longitudinal specialty care. These and other challenges have created a niche for a multidisciplinary team which can respond rapidly to unstable patient scenarios, appropriately deploy resources, and offer highly specialized acute and chronic management of PE. The Massachusetts General Hospital Pulmonary Embolism Response Team (PERT), modeled after existing rapid response and collaborative care teams, is a novel approach that combines this clinical service with the development of an educational and research framework to advance the care of patients with PE.

show abstract

Inpatient Resource Use and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States

Cited by 65 publications

References 14 publications

Cardiac Troponins in Low‐Risk Pulmonary Embolism Patients: A Systematic Review and Meta‐Analysis

Cardiac Troponins in Low‐Risk Pulmonary Embolism Patients: A Systematic Review and Meta‐Analysis

Development of an Education Program for Registered Nurses Related to the Use and Function of Mechanical Prophylaxis

Pulmonary Embolism Response Teams

Contact Info

Product

Resources

About